Helping Daytona Beach patients explore new treatments for sleep apnea & hypertension through safe, expertly managed clinical studies.
We are conducting a research study to learn more about a new medication called lorundrostat for people who have moderate to severe obstructive sleep apnea (OSA) and high blood pressure (hypertension). The goal of the study is to see whether this medication can improve sleep apnea symptoms and help manage blood pressure.
In this study, participants will take either the study drug or a placebo. Neither you nor the study team will know which one you’re taking during each treatment period. Everyone in the study will have the chance to receive both the study drug and the placebo at different times.
The study will last about 13 weeks and includes:
A 3-week screening period to confirm eligibility.
Two treatment periods (4 weeks each), separated by a 2-week break.
During the treatment periods, participants will take either lorundrostat or placebo once a day by mouth.
By joining, participants receive study-related medical care and help researchers explore new treatment options for sleep apnea and high blood pressure.
Ages 18 to 75
All genders welcome
Obstructive sleep apnea (OSA) and high blood pressure
Daytona Beach, FL
Fill out the form below to see if you qualify for our sleep apnea & hypertension study in Daytona Beach. Participation is completely voluntary, and all study-related care will be provided at no cost to you.
Why Join?
Participating in a clinical trial at Arrow Clinical Trials in Daytona Beach, is an opportunity to take charge of your health while helping advance medical science. All while under the care of experienced local physicians.
Yes. People who use CPAP or autoPAP therapy may qualify, as long as they’ve been using it regularly for at least 3 months. People not using PAP therapy may also be eligible.
We currently conduct research studies in Hypertension, Orthopedics, Cardiology, and Neurology.
Our trials include treatments for high blood pressure, joint pain, heart health, stroke recovery, migraines, and other conditions affecting the brain and nervous system.
Participants will take either the study drug or placebo by mouth once a day for 4 weeks at a time, with a short break between treatment periods.
No. All studies at Arrow Clinical Trials are provided at no cost to participants, and insurance is not required.
Any procedures, tests, or study-related care will be covered by the trial sponsor.
Yes. Participants may receive compensation for their time and travel. The exact amount depends on the study and the number of visits required.
Each study has specific requirements, such as age range, medical history, and current health status.
Our research team will review your information and conduct a screening process to determine if you qualify.